BioCentury
ARTICLE | Management Tracks

CVS’s Asgarian joins Thrive as CMO; plus Black Diamond names Ingram chairman and updates from MorphoSys, G1 and more

October 1, 2020 2:04 AM UTC

Liquid biopsy company  Thrive Earlier Detection Corp. hired Sam Asgarian as CMO, Frank Diehl as EVP of product solutions and Dina Ciarimboli as chief legal officer. Before joining Thrive, Asgarian was VP of the transformation health product organization at CVS Health Corp. (NYSE:CVS); Diehl was CEO of the Sysmex Inostics subsidiary of Sysmex Corp.; and Ciarimboli was general counsel at Third Rock Ventures. 

Precision oncology company Black Diamond Therapeutics Inc. (NASDAQ:BDTX) has named Robert Ingram as chairman. Ingram is a general partner at Hatteras Venture Partners and succeeds Brad Bolzon, who will remain on the company’s board. ...